Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Brunelli

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Data in Brief|June 15, 2018
Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblastsPaola Altieri, Maria Bertolotto, Patrizia Fabbi, et al.
Minerva Cardioangiologica|July 20, 2016
Biophysical aspects and novel treatments of atrial fibrillationLorenzo Gigli, Gian M Rosa, Maria I Tagliasacchi, et al.
Molecular Biology Reports|February 8, 2012
Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytesSilvano Garibaldi, Chiara Barisione, Giorgio Ghigliotti, et al.
Cardiovascular Research|October 11, 2005
Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidasePaolo Spallarossa, Paola Altieri, Silvano Garibaldi, et al.
Biochemical and Biophysical Research Communications|August 2, 2005
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosisPaolo Spallarossa, Patrizia Fabbi, Valeria Manca, et al.
American Journal of Hypertension|March 19, 2014
Impact of central obesity on the estimation of carotid-femoral pulse wave velocityMarco Canepa, Majd AlGhatrif, Gabriele Pestelli, et al.
Chemotherapy|March 7, 2019
Ivabradine in Cancer Treatment-Related Left Ventricular DysfunctionMatteo Sarocchi, Eleonora Arboscello, Giorgio Ghigliotti, et al.
International Journal of Cardiology|February 6, 2019
Arterial hypertension in cancer: The elephant in the roomGiacomo Tini, Matteo Sarocchi, Giuliano Tocci, et al.
International Journal of Cardiology|May 27, 2018
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effectsPaola Altieri, Maria Bertolotto, Patrizia Fabbi, et al.
World Journal of Clinical Cases|February 15, 2014
Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a caseGian Marco Rosa, Antonello Parodi, Ulrico Dorighi, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Data in Brief|June 15, 2018
Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblastsPaola Altieri, Maria Bertolotto, Patrizia Fabbi, et al.
Minerva Cardioangiologica|July 20, 2016
Biophysical aspects and novel treatments of atrial fibrillationLorenzo Gigli, Gian M Rosa, Maria I Tagliasacchi, et al.
Molecular Biology Reports|February 8, 2012
Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytesSilvano Garibaldi, Chiara Barisione, Giorgio Ghigliotti, et al.
Cardiovascular Research|October 11, 2005
Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidasePaolo Spallarossa, Paola Altieri, Silvano Garibaldi, et al.
Biochemical and Biophysical Research Communications|August 2, 2005
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosisPaolo Spallarossa, Patrizia Fabbi, Valeria Manca, et al.
American Journal of Hypertension|March 19, 2014
Impact of central obesity on the estimation of carotid-femoral pulse wave velocityMarco Canepa, Majd AlGhatrif, Gabriele Pestelli, et al.
Chemotherapy|March 7, 2019
Ivabradine in Cancer Treatment-Related Left Ventricular DysfunctionMatteo Sarocchi, Eleonora Arboscello, Giorgio Ghigliotti, et al.
International Journal of Cardiology|February 6, 2019
Arterial hypertension in cancer: The elephant in the roomGiacomo Tini, Matteo Sarocchi, Giuliano Tocci, et al.
International Journal of Cardiology|May 27, 2018
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effectsPaola Altieri, Maria Bertolotto, Patrizia Fabbi, et al.
World Journal of Clinical Cases|February 15, 2014
Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a caseGian Marco Rosa, Antonello Parodi, Ulrico Dorighi, et al.
Pageof 11